186 related articles for article (PubMed ID: 33175511)
1. Druggable Hot Spots in the Schistosomiasis Cathepsin B1 Target Identified by Functional and Binding Mode Analysis of Potent Vinyl Sulfone Inhibitors.
Jílková A; Rubešová P; Fanfrlík J; Fajtová P; Řezáčová P; Brynda J; Lepšík M; Mertlíková-Kaiserová H; Emal CD; Renslo AR; Roush WR; Horn M; Caffrey CR; Mareš M
ACS Infect Dis; 2021 May; 7(5):1077-1088. PubMed ID: 33175511
[TBL] [Abstract][Full Text] [Related]
2. Structural and Functional Characterization of Schistosoma mansoni Cathepsin B1.
Jílková A; Horn M; Mareš M
Methods Mol Biol; 2020; 2151():145-158. PubMed ID: 32452002
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for inhibition of cathepsin B drug target from the human blood fluke, Schistosoma mansoni.
Jílková A; Řezáčová P; Lepšík M; Horn M; Váchová J; Fanfrlík J; Brynda J; McKerrow JH; Caffrey CR; Mareš M
J Biol Chem; 2011 Oct; 286(41):35770-35781. PubMed ID: 21832058
[TBL] [Abstract][Full Text] [Related]
4. Nature-Inspired Gallinamides Are Potent Antischistosomal Agents: Inhibition of the Cathepsin B1 Protease Target and Binding Mode Analysis.
Spiwoková P; Horn M; Fanfrlík J; Jílková A; Fajtová P; Leontovyč A; Houštecká R; Bieliková L; Brynda J; Chanová M; Mertlíková-Kaiserová H; Caro-Diaz EJE; Almaliti J; El-Sakkary N; Gerwick WH; Caffrey CR; Mareš M
ACS Infect Dis; 2024 Jun; 10(6):1935-1948. PubMed ID: 38757505
[TBL] [Abstract][Full Text] [Related]
5. Azanitrile Inhibitors of the SmCB1 Protease Target Are Lethal to
Jílková A; Horn M; Fanfrlík J; Küppers J; Pachl P; Řezáčová P; Lepšík M; Fajtová P; Rubešová P; Chanová M; Caffrey CR; Gütschow M; Mareš M
ACS Infect Dis; 2021 Jan; 7(1):189-201. PubMed ID: 33301315
[TBL] [Abstract][Full Text] [Related]
6. Mapping the pro-peptide of the Schistosoma mansoni cathepsin B1 drug target: modulation of inhibition by heparin and design of mimetic inhibitors.
Horn M; Jílková A; Vondrásek J; Maresová L; Caffrey CR; Mares M
ACS Chem Biol; 2011 Jun; 6(6):609-17. PubMed ID: 21375333
[TBL] [Abstract][Full Text] [Related]
7. Quantum mechanics-based scoring rationalizes the irreversible inactivation of parasitic Schistosoma mansoni cysteine peptidase by vinyl sulfone inhibitors.
Fanfrlík J; Brahmkshatriya PS; Řezáč J; Jílková A; Horn M; Mareš M; Hobza P; Lepšík M
J Phys Chem B; 2013 Dec; 117(48):14973-82. PubMed ID: 24195769
[TBL] [Abstract][Full Text] [Related]
8. Protective immune responses against Schistosoma mansoni infection by immunization with functionally active gut-derived cysteine peptidases alone and in combination with glyceraldehyde 3-phosphate dehydrogenase.
Tallima H; Dvořák J; Kareem S; Abou El Dahab M; Abdel Aziz N; Dalton JP; El Ridi R
PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005443. PubMed ID: 28346516
[TBL] [Abstract][Full Text] [Related]
9. Dual Strategy to Design New Agents Targeting
Fuchs N; Zimmermann RA; Schwickert M; Gunkel A; Zimmer C; Meta M; Schwickert K; Keiser J; Haeberli C; Kiefer W; Schirmeister T
ACS Infect Dis; 2024 May; 10(5):1664-1678. PubMed ID: 38686397
[TBL] [Abstract][Full Text] [Related]
10. Activation route of the Schistosoma mansoni cathepsin B1 drug target: structural map with a glycosaminoglycan switch.
Jílková A; Horn M; Řezáčová P; Marešová L; Fajtová P; Brynda J; Vondrášek J; McKerrow JH; Caffrey CR; Mareš M
Structure; 2014 Dec; 22(12):1786-1798. PubMed ID: 25456815
[TBL] [Abstract][Full Text] [Related]
11. Functional expression and characterization of Schistosoma mansoni cathepsin B and its trans-activation by an endogenous asparaginyl endopeptidase.
Sajid M; McKerrow JH; Hansell E; Mathieu MA; Lucas KD; Hsieh I; Greenbaum D; Bogyo M; Salter JP; Lim KC; Franklin C; Kim JH; Caffrey CR
Mol Biochem Parasitol; 2003 Sep; 131(1):65-75. PubMed ID: 12967713
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of a sugar-based thiosemicarbazone series and structure-activity relationship versus the parasite cysteine proteases rhodesain, cruzain, and Schistosoma mansoni cathepsin B1.
Fonseca NC; da Cruz LF; da Silva Villela F; do Nascimento Pereira GA; de Siqueira-Neto JL; Kellar D; Suzuki BM; Ray D; de Souza TB; Alves RJ; Sales Júnior PA; Romanha AJ; Murta SM; McKerrow JH; Caffrey CR; de Oliveira RB; Ferreira RS
Antimicrob Agents Chemother; 2015 May; 59(5):2666-77. PubMed ID: 25712353
[TBL] [Abstract][Full Text] [Related]
13. Targeting SmCB1: Perspectives and Insights to Design Antischistosomal Drugs.
Dos Santos Nascimento IJ; Albino SL; da Silva Menezes KJ; de Azevedo Teotônio Cavalcanti M; de Oliveira MS; Mali SN; de Moura RO
Curr Med Chem; 2024; 31(16):2264-2284. PubMed ID: 37921174
[TBL] [Abstract][Full Text] [Related]
14. Vector-based RNA interference of cathepsin B1 in Schistosoma mansoni.
Tchoubrieva EB; Ong PC; Pike RN; Brindley PJ; Kalinna BH
Cell Mol Life Sci; 2010 Nov; 67(21):3739-48. PubMed ID: 20339897
[TBL] [Abstract][Full Text] [Related]
15. Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor.
Abdulla MH; Lim KC; Sajid M; McKerrow JH; Caffrey CR
PLoS Med; 2007 Jan; 4(1):e14. PubMed ID: 17214506
[TBL] [Abstract][Full Text] [Related]
16. Schistosome asparaginyl endopeptidase (legumain) is not essential for cathepsin B1 activation in vivo.
Krautz-Peterson G; Skelly PJ
Mol Biochem Parasitol; 2008 May; 159(1):54-8. PubMed ID: 18280591
[TBL] [Abstract][Full Text] [Related]
17. Long-term suppression of cathepsin B levels by RNA interference retards schistosome growth.
Correnti JM; Brindley PJ; Pearce EJ
Mol Biochem Parasitol; 2005 Oct; 143(2):209-15. PubMed ID: 16076506
[TBL] [Abstract][Full Text] [Related]
18. Pharmacophore Virtual Screening Identifies Riboflavin as an Inhibitor of the Schistosome Cathepsin B1 Protease with Antiparasitic Activity.
Cogo RM; Pavani TFA; Mengarda ACA; Cajas RA; Teixeira TR; Fukui-Silva L; Sun YU; Liu LJ; Amarasinghe DK; Yoon MC; Santos-Filho OA; de Moraes J; Caffrey CR; G G Rando D
ACS Omega; 2024 Jun; 9(23):25356-25369. PubMed ID: 38882094
[TBL] [Abstract][Full Text] [Related]
19. Targeting the Schistosoma mansoni nutritional mechanisms to design new antischistosomal compounds.
Pavani TFA; Cirino ME; Teixeira TR; de Moraes J; Rando DGG
Sci Rep; 2023 Nov; 13(1):19735. PubMed ID: 37957227
[TBL] [Abstract][Full Text] [Related]
20. Protection against Schistosoma haematobium infection in hamsters by immunization with Schistosoma mansoni gut-derived cysteine peptidases, SmCB1 and SmCL3.
Tallima H; Abou El Dahab M; Kareem S; Dalton JP; El Ridi R
Vaccine; 2017 Dec; 35(50):6977-6983. PubMed ID: 29122387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
